[go: up one dir, main page]

WO2012127500A3 - Composition pour la spermatogenèse - Google Patents

Composition pour la spermatogenèse Download PDF

Info

Publication number
WO2012127500A3
WO2012127500A3 PCT/IN2012/000165 IN2012000165W WO2012127500A3 WO 2012127500 A3 WO2012127500 A3 WO 2012127500A3 IN 2012000165 W IN2012000165 W IN 2012000165W WO 2012127500 A3 WO2012127500 A3 WO 2012127500A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
spermatogenesis
gonadotropins
present
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2012/000165
Other languages
English (en)
Other versions
WO2012127500A2 (fr
Inventor
K. V. S. Prasad
Jay L. SOMAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SANZYME Ltd
Original Assignee
SANZYME Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SANZYME Ltd filed Critical SANZYME Ltd
Publication of WO2012127500A2 publication Critical patent/WO2012127500A2/fr
Publication of WO2012127500A3 publication Critical patent/WO2012127500A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des compositions comprenant une combinaison de gonadotrophines pour promouvoir la spermatogenèse chez les hommes. L'invention concerne en particulier une composition comprenant un mélange de gonadotrophines choisies, de façon non limitative, dans le groupe comprenant l'hormone folliculostimulante (FSH), l'hormone lutéinisante (LH) et la gonadotrophine chorionique humaine (hCG), ainsi que des formulations pharmaceutiques comprenant cette composition.
PCT/IN2012/000165 2011-03-11 2012-03-12 Composition pour la spermatogenèse Ceased WO2012127500A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN692MU2011 2011-03-11
IN692/MUM/2011 2011-03-11

Publications (2)

Publication Number Publication Date
WO2012127500A2 WO2012127500A2 (fr) 2012-09-27
WO2012127500A3 true WO2012127500A3 (fr) 2013-03-14

Family

ID=46879829

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2012/000165 Ceased WO2012127500A2 (fr) 2011-03-11 2012-03-12 Composition pour la spermatogenèse

Country Status (1)

Country Link
WO (1) WO2012127500A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110787286B (zh) * 2019-11-21 2024-06-25 重庆市畜牧科学院 Fsh和hcg在制备促进睾丸细胞功能恢复的药物中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508261A (en) * 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
US5929028A (en) * 1997-01-15 1999-07-27 Akzo Nobel, N.V. Liquid gonadotropin containing formulations
US7741268B2 (en) * 2003-04-02 2010-06-22 Ares Trading S.A. Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant
US7964562B2 (en) * 2003-06-03 2011-06-21 Ferring B.V. Unitary combinations of FSH and hCG

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508261A (en) * 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
US5929028A (en) * 1997-01-15 1999-07-27 Akzo Nobel, N.V. Liquid gonadotropin containing formulations
US7741268B2 (en) * 2003-04-02 2010-06-22 Ares Trading S.A. Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant
US7964562B2 (en) * 2003-06-03 2011-06-21 Ferring B.V. Unitary combinations of FSH and hCG

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PETSCH ET AL.: "Endotoxin removal from protein solutions.", JOUMAL OF BIOTECHNOLOGY, vol. 76, 2000, pages 97 - 119, XP002296265, DOI: doi:10.1016/S0168-1656(99)00185-6 *

Also Published As

Publication number Publication date
WO2012127500A2 (fr) 2012-09-27

Similar Documents

Publication Publication Date Title
WO2011062437A3 (fr) Antagonistes des récepteurs de l'hormone de libération des gonadotrophines, leurs procédés de production et composition pharmaceutique les contenant
UA99337C2 (ru) Жидкая лекарственная форма фсг
NZ630826A (en) Anti-egfr antibody drug conjugate formulations
MY153976A (en) Lh liquid formulations
WO2013121384A3 (fr) Mélanges pour réduire l'émission d'oxyde nitreux et/ou d'ammoniac à partir des sols
GB0906579D0 (en) Pharmaceuticals, compositions and methods of making and using the same
PE20142192A1 (es) Forma de dosificacion farmaceutica que comprende nifedipino o nisoldipino y un antagonista de angiotensina ii y/o diuretico
MXPA06014798A (es) Antagonistas del receptor de hormona para liberar gonadotropina.
MX2011007817A (es) Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion.
WO2008112159A3 (fr) Antagonistes des récepteurs cgrp d'anilide spirolactame monocyclique
IN2012DN02861A (fr)
WO2013057741A3 (fr) Compositions pharmaceutiques d'acide ursodésoxycholique
MEP31708A (en) Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant
WO2006058012A3 (fr) Antagonistes du recepteur d'hormone de liberation de gonadotropine
WO2012014073A3 (fr) Vaccins dirigés contre le paludisme lié à la grossesse
MY193138A (en) Stable liquid gonadotropin formulation
WO2012127500A3 (fr) Composition pour la spermatogenèse
MX342098B (es) Preparacion farmaceutica que contiene selenita o compuestos que contienen selenita para el tratamiento de displasias cervicales o carcinomas.
HRP20150968T4 (hr) Pripravak za uporabu za liječenje neplodnosti
MX2015011624A (es) Composiciones farmaceuticas secas que comprenden nanoparticulas de agente activo ligadas a particulas portadoras.
WO2014166836A8 (fr) Formulation de composés d'hormone de croissance
WO2014167579A3 (fr) Compositions pharmaceutiques stables de tadalafil
WO2008063898A3 (fr) Méthodes de traitement de la purpura thrombopénique idiopathique dans lesquelles est utilisé un antagoniste du gm-csf
WO2011139249A3 (fr) Composition pharmaceutique renfermant du cefdinir
WO2012168680A8 (fr) Préparation pharmaceutique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12760733

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12760733

Country of ref document: EP

Kind code of ref document: A2